Skip to main content
Open Access Publications from the University of California

Ovarian stimulation in young adult cancer survivors on targeted cancer therapies.

  • Author(s): Su, H Irene
  • Connell, Meghan W
  • Bazhenova, Lyudmila A
  • et al.

Published Web Location
No data is associated with this publication.

To describe a clinical approach to and outcomes of IVF in reproductive-aged cancer survivors receiving targeted cancer therapies.Case report.Not applicable.The first case is of a female patient with metastatic lung cancer receiving long-term crizotinib, an anaplastic lymphoma kinase inhibitor. The second case is of a female patient with metastatic colon cancer receiving long-term denosumab, a RANKL antibody. Both patients presented desiring fertility.In vitro fertilization.Live birth and embryo banking.The potential impact of targeted therapy on oocytes and pregnancy was investigated via literature review and pharmaceutical company inquiries. After oncologic, fertility, and psychological counseling, both survivors underwent ovarian stimulation, IVF, and preimplantation genetic screening. One couple achieved live births of dizygotic twins via gestational surrogacy. The second couple froze one euploid blastocyst for future fertility. Both survivors are stable from their cancer standpoints.Successful fertility treatments are possible in the context of exposure to crizotinib and denosumab.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item